CD59 Antibody (193-27)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-44698
Clone 193-27 was used by HLDA to establish CD designation.
Key Product Details
Species Reactivity
Validated:
Human, Baboon (Negative), Equine (Negative)
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgM Kappa Clone # 193-27
Concentration
0.2 mg/ml
Product Summary for CD59 Antibody (193-27)
Immunogen
Stimulated human leukocytes
Reactivity Notes
Does not react with Baboon or Equine.
Localization
Cell Surface
Specificity
Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein (Workshop VI; Code N-L036). CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This monoclonal antibody recognizes CD59 transfected cells. It is useful for study on GPI-anchored proteins, PNH and CD59 functions.
Clonality
Monoclonal
Host
Mouse
Isotype
IgM Kappa
Theoretical MW
20 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Description
200ug/ml of antibody purified from Bioreactor Concentrate. Prepared in 10 mM PBS with 0.05% BSA % 0.05% azide. Also available WITHOUT BSA & azide at 1.0 mg/ml.(NBP3-11474)
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Scientific Data Images for CD59 Antibody (193-27)
Immunohistochemistry-Paraffin: CD59 Antibody (193-27) [NBP2-44698]
Immunohistochemistry-Paraffin: CD59 Antibody (193-27) [NBP2-44698] - Formalin-fixed, paraffin-embedded human bladder stained with CD59 Antibody (193-27).Immunohistochemistry-Paraffin: CD59 Antibody (193-27) [NBP2-44698]
Immunohistochemistry-Paraffin: CD59 Antibody (193-27) [NBP2-44698] - Formalin-fixed, paraffin-embedded human bladder stained with CD59 Antibody (193-27).Applications for CD59 Antibody (193-27)
Application
Recommended Usage
Flow Cytometry
1-2 ug/million cells
Immunocytochemistry/ Immunofluorescence
1-2 ug/ml
Immunofluorescence
0.5 - 1.0 ug/ml
Immunohistochemistry
1:10-1:500
Immunoprecipitation
2-4 ug/mg
Western Blot
1:500-1000
Application Notes
Optimal dilution for a specific application should be determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein L or PEG purified
Formulation
10 mM PBS with 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: CD59
Additional CD59 Products
Product Documents for CD59 Antibody (193-27)
Product Specific Notices for CD59 Antibody (193-27)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...